Viewing StudyNCT03603951



Ignite Creation Date: 2024-05-06 @ 11:47 AM
Last Modification Date: 2024-10-26 @ 12:50 PM
Study NCT ID: NCT03603951
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2022-04-29
First Post: 2018-07-10

Brief Title: A Phase 1 Study of SHR2554 in Subjects With Relapsed or Refractory Mature Lymphoid Neoplasms
Sponsor: Jiangsu HengRui Medicine Co Ltd
Organization: Jiangsu HengRui Medicine Co Ltd

Conditions & Keywords Data

Conditions:
Name
Relapsed or Refractory Mature Lymphoid Neoplasms
Keywords:
Name View
SHR2554 View
EZH2 inhibitor View
phase 1 View
mature lymphoid neoplasm View